| Financial Year |
March 31 2023 |
| Monetary Funds |
332,458,620.35 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
32,040,172.38 |
| Accounts Receivable |
197,020,226.15 |
| Advances to Suppliers |
342,442.00 |
| Other Receivables |
2,600,603.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
38,827,852.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,913,912.41 |
| Total Current Assets |
747,387,147.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,211,299.64 |
| Investment Properties |
-- |
| Fixed Assetes |
376,130,668.13 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,634,893.04 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,193,032.63 |
| Deferred Income Tax Assets |
22,844,003.92 |
| Other Non-Current Assets |
4,454,797.15 |
| Sub-Total of Non-Current Assets |
470,113,219.24 |
| Total Assets |
1,217,500,366.95 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
86,043,801.09 |
| Accounts Payable |
153,826,002.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,570,045.00 |
| Taxes Payable |
2,604,451.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,398,764.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,406,434.30 |
| Other Current Liabilities |
14,864,866.42 |
| Sub-Total of Current Liabilities |
293,915,564.03 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
77,108,866.68 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,685,032.24 |
| Other Non-Current Liabilities |
20,000.00 |
| Sub-Total of Non-Current Liabilities |
131,754,761.65 |
| Total Liabilities |
425,670,325.68 |
| Paid-In Capital(Or Share Stock) |
190,572,083.00 |
| Capital Surplus |
464,115,448.80 |
| Surplus Reserve |
24,754,167.48 |
| LESS:Treasury Stock |
10,301,540.88 |
| Undistributed Profits |
122,710,934.05 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
791,830,041.27 |
| Owner's Equity（Stockholder's Equity） |
791,830,041.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,217,500,366.95 |
